Previous Page  17 / 17
Information
Show Menu
Previous Page 17 / 17
Page Background

Medchem & Toxicology 2018

Page 48

Journal of Organic & Inorganic Chemistry

ISSN: 2472-1123

A n n u a l C o n g r e s s o n

Medicinal Chemistry,

Pharmacology and toxicology

J u l y 3 0 - 3 1 , 2 0 1 8

Am s t e r d a m , N e t h e r l a n d s

C

ancer-associated mucin glycoprotein MUC1 is characterized by the

presence of altered carbohydrates such as Tn (-N-acetylgalactosamine),

sTn (sialyl-1-6-Tn) and the Thomsen-Friedenreich (TF: -D-Galp-1-3-D-

GalNAcp) antigen (tumor associated carbohydrate antigens: TACAs) that

are conjugated to proteins via O--galactosylation of serine or/and threonine.

Patients immunized with synthetic TF conjugated with KLH (keyhole limpet

hemocyanin) + QS21 adjuvant can generate IgM and IgG antibodies.1 Because

the disaccharide TF is hydrolyzed rapidly in the body, strong immune response

requires longer lived disaccharides. Fluororinated TACAs have been proposed

which elicit IgG antibodies found to cross-react with native TF epitopes.2,3 We

have found that the C-linked disaccharide analogue 1 (constructed applying

Danishesky's method for the conjugation with KLH 4) + QS21 adjuvant induces

a strong immune response in mice. Interestingly, much weaker immune

response was observed with a stereoisomeric antigen constructed with the

-C-galactoside analogue of TF disaccharide (-D-Galp-1-CH2-3--D-GalNAc-O-

Ser).5 Several strategies and methods have been developed for the synthesis

of C-linked disaccharides including disaccharide mimetics incorporating

iminosugars C-linked to sugars and sugar mimetics such as conduritols and

cyclitols. The latter work was motivated by the search for specific glycosidase

and glycosyltransferase inhibitors that are potential drugs against cancers and

other diseases.

Biography

P. Vogel was born in Cully (Switzerland) Oct. 23, 1944. In 1969,

he did his Ph.D under supervision of Prof. H. Prinzbach at the

Institute of Organic Chemistry, University of Lausanne. He spent

two years at Yale University, New Haven, Connecticut, USA with

Prof. Martin Saunders, Prof. J. A. Berson, K. A. Wiberg and P.v.R.

Schleyer (Princeton Universtiy). He worked then as a Research

chemist at Syntex S.A., in Mexico with Prof. P.Crabbé before

the return to the University of Lausanne in 1973. As of 1977

he became Professor of organic chemistry at the University

of Lausanne. In 1991 he was Vice-Chairman of the Institute of

organic Chemistry, University of Lausanne until 2001. He was

also part-time grad.school teacher at the Universities of Rouen

and Caen from 1991 to 1993 and Part-time professor at Ecole

Polytechnique de Palaiseau from 1993-2000. Since 2001 he is

Professor of organic chemistry at the EPFL.

Pierre.vogel@epfl.ch

Sugar mimetics toward an anti-cancer therapeutic vaccine

Pierre Vogel and Loay Awad

Swiss Institute of Technology in Lausanne (EPFL), CH 1015 Lausanne, Switzerland

Pierre Vogel et al., J Org Inorg Chem 2018, Volume 4

DOI: 10.21767/2472-1123-C3-008

O

O

HO OH HO

OH

NH

OH

HO

O

H

H Ac

CO-

HN

NH-spacer

R

3

1

KLH

230